Solventum Publishes Q3 2026 Earnings Call Transcript

By Public Technologies
  • Solventum’s Q3 fiscal 2026 earnings call on November 5 featured CEO Bryan Hanson and CFO Wayde McMillan.
  • Adjusted EPS guidance rose to $7.20-$7.30 from $7.10-$7.20; organic sales growth is expected near the top of the 2.5%-3% range.
  • Quarterly sales fell 7% to $1.95 billion, reflecting ERP-related order reversals; normalized organic growth was approximately 4%.
  • Management is considering a spin-off or sale of Health Information Systems, with approximately 400 basis points of anticipated operating margin dilution.
  • A renegotiated 3M supply agreement eliminates a potential 100-basis-point gross margin headwind; management expects operating margin expansion in 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solventum Corporation published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.